Woman on laptop viewing Sharesource remote patient management

Sharesource Connectivity Platform Remote Patient Management

Enhancing APD programs with the Sharesource Connectivity Platform

Sharesource Connectivity Platform is a two-way remote patient management (RPM) platform that enables healthcare professionals to securely view and act upon APD patients' treatment data, including adjusting patients' device programs without an additional trip to the clinic.1

With over 60 million treatments delivered globally, including 20 million in the U.S., the Sharesource Connectivity Platform is the most evidenced remote PD patient management technology available.2

Personalized care

Sharesource Connectivity Platform provides the treatment data healthcare professionals need to review and, if necessary, use to adjust treatment,  in order to personalize their patients’ therapy remotely and with confidence.

A growing body of evidence shows that Sharesource Connectivity Platform may help reduce patient complications3,4 and hospitalizations5-7 and promote treatment adherence8,9 — with the goal of improving patient outcomes and clinic resource optimization.

Healthcare professional views an online learning resource on a laptop at her desk
Making informed decisions

With on-demand access to historical treatment data, Sharesource Connectivity Platform can help clinicians make informed treatment decisions for patients.

Improving patient compliance

The Sharesource Connectivity Platform Clinical Dashboard indicates when a patient stops a treatment early or skips a treatment altogether. This may help identify and resolve compliance issues with prescribed treatments.

Increasing clinic efficiencies

Tracking treatment data in Sharesource Connectivity Platform for multiple patients offers the potential to improve clinic efficiencies by enabling prioritization of resources.

Implementation that is simple by design

Vantive provides the modem for patient devices, and Sharesource Connectivity Platform utilizes cloud-based technology, so there is little-to-no IT investment required. All that is needed is an internet connection at the clinic.

Compelling evidence to use an APD cycler with the Sharesource Connectivity Platform for remote patient management

Sharesource Connectivity Platform is the most evidenced based two-way remote PD patient management technology available.8,10-13

Transparent patient adherence8

Establishes transparency to patient adherence patterns and may facilitate early intervention.

See the evidence

Proactive patient management10

Enables clinicians to spend a greater proportion of time on proactive patient care.

See the evidence

Improved fluid management11

With Sharesource Connectivity Platform, remote management of patients is ensured, and patients are actively kept in treatment. As a result, ultrafiltration and dialysis efficiency of patients increase with improved treatment adherence, and blood pressure regulation can be achieved with fewer antihypertensive drugs.

See the evidence

Reduction in hospitalization5

The remote monitoring technology specifically designed to be integrated into APD systems gives both patients and their clinical teams a powerful tool that can enhance communication, potentially improve adherence to treatment, and provide the potential for early intervention of complications of therapy.

See the evidence

Reduction in drop-out12

Retrospective, multicenter, observational cohort study of 558 prevalent adult APD patients demonstrated a lower drop-out rate in the APD-RPM cohort versus the APD cohort.

See the evidence

Increased time on therapy13

Retrospective, observational, multicenter, cohort study of 574 incident patients undergoing APD (propensity matched) demonstrated that APD patients with RPM remained on PD 3.2 months longer than those without RPM.

See the evidence

Reduction in resource utilization14

A simulated study that estimates the potential impact of RPM on APD patients’ use of healthcare resources and costs in the U.S., Germany and Italy.

See the evidence

Sharesource Analytics 1.0

Through seamless integration with the Sharesource Clinical Portal, Analytics 1.0 is designed to transform patient treatment data into actionable insight.

Explore visualizations of therapy data, trend notifications and clinical decision support – all available through Sharesource Analytics 1.0.

Learn more about Sharesource Analytics 1.0
Sharesource Analytics 1.0
Learn more about Sharesource Analytics 1.0

Our automated peritoneal dialysis systems

Sharesource Connectivity Platform is available with our automated peritoneal dialysis (APD) systems. Learn more about our Homechoice Claria APD and Amia APD systems.

Explore the MySharesource app for Homechoice Claria for optimal implementation

The MySharesource web-based app was built to expand familiarity with the platform’s capabilities, in order to best utilize the remote patient management platform in the care of Homechoice Claria patients.

Access the MySharesource app for Homechoice Claria

Important Safety Information

Intended Use

The Sharesource Connectivity Platform is intended for use by healthcare professionals to remotely communicate new or modified treatment parameters with compatible dialysis instruments and transfer completed treatment data to a central database to aid in the review, analysis, and evaluation of patients’ historical treatment results. This system is not intended to be a substitute for good clinical management practices, nor does its operation create decisions or treatment pathways.

Rx Only. For safe and proper use of the products mentioned herein, please refer to the appropriate Operator’s Manual or Instructions for Use.

 

Vantive, Amia, Homechoice Claria and Sharesource are trademarks of Vantive Health LLC or its affiliates.

References

  1. Vantive Health LLC. Amia Automated PD System Clinical Guide. 07-19-72-060F1.

  2. Vantive Health LLC. Sharesource Global Treatment Data. Accessed September 2023.

  3. Gomez R, et al. Abstract P222 presented at: 13th Euro-PD congress. 2017. Dublin, Ireland.

  4. Rojas-Diaz M, Ramos A. Help of remote patient monitoring in the assessment of changes in ultrafiltration before, during, and after a peritonitis episode in patients on automated peritoneal dialysis. Abstract TH-PO859 presented at: ASN Kidney Week; Oct. 31-Nov. 5, 2017; New Orleans, LA, U.S. 2017. 

  5. Sanabria M, Buitrago G, Lindholm B, et al. Remote patient monitoring program in automated peritoneal dialysis: impact on hospitalizations. Perit Dial Int. 2019;39(5):472-478.

  6. Uchiyama K, Washida N, Yube N, et al. The impact of a remote monitoring system of healthcare resource consumption in patients on automated peritoneal dialysis (APD): a simulation study. Clin Nephrol. 2018;90(5):334-340.

  7. Laplante S, Mcleod K, Danek J, et al. Remote monitoring of patients on automated peritoneal dialysis saves healthcare resources in a simulation study. Abstract SA-PO483 presented at: ASN Kidney Week; Nov. 15-20, 2016; Chicago, IL, U.S.

  8. Firanek C, Salas M, Gellens M, et al. MP557 Discrepancy between prescribed and actual APD prescription delivery: Identification using cycler remote management technology. Neph Dial Trans. 2017;32(suppl 3):iii633.

  9. Jotterand Drepper V, Martin, PY, Stoermann Chopard C, et al. Remote patient management in automated peritoneal dialysis: a promising new tool. Perit Dial Int. 2018;38:76-78.

  10. Wood E, McCarthy K, Roper M. Remote monitoring of peritoneal dialysis: evaluating the impact of the Claria Sharesource system. J. Kidney Care. 2019;4(1):16-24.

  11. Yeter H, Akcay OF, Ronco C, Derici U. Automated remote monitoring for peritoneal dialysis and its impact on blood pressure. Cardiorenal Med. 2020;10(3):198-208.

  12. Corzo L, Vesga J, Sanabria M, Rivera A. Clinical outcomes in remote patient monitoring program in automated peritoneal dialysis: a Colombian experience. Neph Dial Trans. 2018;35(3):1151.

  13. Sanabria M, Vesga J, Lindholm B, Rivera A, Rutherford P. Time on therapy of automated peritoneal dialysis with and without remote patient monitoring: a cohort study. Int J Nephrol. 2022;2022:8646775.

  14. Makhija D, Alscher MD, Becker S, et al. Remote monitoring of apd patients: assessing clinical and economic value. Telemed J E Health. 2018;24(4):315-323.